Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Agricultural Development Bank of China
International Relation

China's overseas phase-3 vaccine trials attract Western media attention

September 04, 2020


Abstract : China's international phase-3 clinical trials of four COVID-19 vaccine candidates have grabbed the attention of the West as mainstream foreign media covered the commencement of the trials.

BEIJING, Sept. 3 (Xinhua) -- China's international phase-3 clinical trials of four COVID-19 vaccine candidates have grabbed the attention of the West as mainstream foreign media covered the commencement of the trials.

Quoting China's National Health Commission, the Financial Times on Tuesday reported the incoming trials, while The New York Times also reported the go-ahead signal given to the trials, with its webpage tracking the latest development of the COVID-19 vaccine research.

Two inactivated COVID-19 vaccines developed by the China National Biotec Group, an inactivated COVID-19 vaccine developed by Sinovac Biotech Co., Ltd., and a recombinant COVID-19 vaccine with the modified defective adenovirus as the vector have started international phase-3 clinical trials.

Phase-3 clinical trials usually involve thousands of people to verify the safety and effectiveness of vaccines, and are key to their market approval. As the epidemic has been brought under control in China, the country no longer has conditions for large-scale clinical trials, so all the phase-3 trials are being carried out overseas.

Some of the trials are expected to conclude their first round of vaccinations in early September, with preliminary data expected as early as November. Enditem

Scan the QR code and push it to your mobile phone

Keyword: vaccine COVID-19

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial